Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34472243 | 0.85 | CA2 (0.36) | CA2CA1CA9 | |
| SCHEMBL12506990 | 0.79 | CA2 (0.39) | CA2CA1CA9 | |
| SCHEMBL26912 | 0.79 | CA2 (0.56) | CA2CA1CA9 | |
| SCHEMBL3524603 | 0.79 | CA2 (0.39) | CA2CA1CA9 | |
| SCHEMBL1855129 | 0.79 | CA2 (0.39) | CA2CA1CA9 | |
| SCHEMBL11613214 | 0.76 | CA2 (0.34) | CA2CA1CA9 | |
| SCHEMBL11617350 | 0.76 | CA2 (0.34) | CA2CA1CA9 | |
| SCHEMBL12643973 | 0.75 | CA2 (0.36) | CA2CA1CA9 | |
| SCHEMBL11612358 | 0.75 | CA2 (0.40) | CA2CA1CA9 | |
| SCHEMBL3242894 | 0.75 | CA2 (0.36) | CA2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102596942-B | Cyclic triazo sodium channel blockers | 格林威治大学 | 2016-11-02 | — | — | CN | disclosed |
| EP-2451806-B1 | CYCLIC TRIAZO SODIUM CHANNEL BLOCKERS | UNIV GREENWICH (GB) | 2016-03-09 | — | — | EP | disclosed |
| US-9000155-B2 | Cyclic triazo sodium channel blockers | UNIVERSITY OF GREENWICH (GB) | 2015-04-07 | — | — | US | disclosed |
| US-20140243343-A1 | CYCLIC TRIAZO SODIUM CHANNEL BLOCKERS | UNIVERSITY OF GREENWICH (GB) | 2014-08-28 | — | — | US | disclosed |
| US-8748599-B2 | Cyclic triazo sodium channel blockers | UNIVERSITY OF GREENWICH (GB) | 2014-06-10 | — | — | US | disclosed |
| CN-102596942-A | Cyclic triazo sodium channel blockers | UNIV GREENWICH | 2012-07-18 | — | — | CN | disclosed |
| US-20120135992-A1 | CYCLIC TRIAZO SODIUM CHANNEL BLOCKERS | UNIVERSITY OF GREENWICH (GB) | 2012-05-31 | — | — | US | disclosed |
| EP-2451806-A2 | CYCLIC TRIAZO SODIUM CHANNEL BLOCKERS | University of Greenwich (GB) | 2012-05-16 | — | — | EP | disclosed |
| WO-2011004195-A2 | CYCLIC TRIAZO SODIUM CHANNEL BLOCKERS | UNIVERSITY OF GREENWICH (GB) | 2011-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135992-A1 | CYCLIC TRIAZO SODIUM CHANNEL BLOCKERS | SCN5A, SCN1B, KCNH2 | CA2 186/4885CA1 1219/4885CA9 2610/4885 |
| US-20140243343-A1 | CYCLIC TRIAZO SODIUM CHANNEL BLOCKERS | SCN5A, SCN1B, KCNH1 | CA2 183/4885CA1 1030/4885CA9 2318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.